You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
STTR Phase I:Solution processed flexible semitransparent organic photovoltaic (OPV) modules for greenhouses
SBC: PolyPV, LLC Topic: ENThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) project is to develop a disruptive technology that reduces the environmental impact of greenhouse-based agriculture while simultaneously improving its economic potential through the application of semitransparent organic solar cells onto the greenhouse glazing (i.e., windows). Greenhouses can be a form of hig ...
STTR Phase I 2023 National Science Foundation -
STTR Phase I:Curved Volume Phase Holographic Gratings: Efficient and High-Resolution Hyperspectral Imaging
SBC: Mike Sullivan Topic: IHThis Small Business Technology Transfer Phase I project will develop a completely new class of spectrometer, the spherical transmission grating spectrometer (STGS), which utilizes curved volume phase holographic (VPH) gratings coupled with a spherical mirror to deliver aberration-corrected spectral images over the full field of view. The market is projected to reach $35.8 billion by 2026, at an an ...
STTR Phase I 2023 National Science Foundation -
STTR Phase I:Rapid Characterization of Wood-based Materials
SBC: SANGALI, INC. Topic: ETThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project will enable the wood industry to certify materials along its entire supply chain, achieving reproducibility and reducing delays in the movement of goods, and supporting the economic competitiveness of American wood companies. The technology being developed by this project entails rapid and acc ...
STTR Phase I 2023 National Science Foundation -
Developing a Novel AI/ML Approach for High-efficiency, High-fidelity Marine Wave Energy Characterization and Assessment for Powering the Blue Economy (PBE)
SBC: FATHOM SCIENCE LLC Topic: C5614aDeveloping regional marine renewable energy resource characterizations and assessments is a significant technical challenge which requires state-of-the-art modeling, application of best modeling practices, accurate model skills, high-quality inputs, and high-performance computing resources. Further, resource characterization and assessment for Powering the Blue Economy markets is needed, especiall ...
STTR Phase I 2023 Department of Energy -
Computer-aided modeling and analysis tools for bioprocess industrialization
SBC: OM BHARTI LLC Topic: C5517aBioprocess development, scaleup and optimization is a significant undertaking. A lack of complete understanding of the underlying biological processes and a shortage of a trained workforce in this field has made the development process slow and inefficient, thus leading to continued reliance on non-renewable petroleum-based chemistries for fuels and chemicals. The overall goal of this project is t ...
STTR Phase I 2023 Department of Energy -
Development of Novel Small Molecule Anti-Fibrotic Agent for the Treatment of Systemic Scleroderma
SBC: APIE THERAPEUTICS INC Topic: NHLBIABSTRACT The goal of this STTR proposal is to develop a novel anti-fibrotic agent suitable for oral administration which could be used to safely and effectively treat Systemic Sclerosis (SSc), or Systemic Scleroderma patients. SSc is one of the most disabling and lethal immune-mediated rheumatic disorders. SSc is a rare disease, affecting 40,000-150,000 people in the United States and conferring a ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
A novel producer cell line for more efficient manufacturing of viral vector systems
SBC: CLAIRIgene Topic: 100ABSTRACT Significant advances in the specific targeting of delivery vectors and the increased therapeutic efficacy of such vectors for gene delivery have been made, stimulating major interest in the development and commercialization of therapeutic products focused on gene therapy indications. CLAIRIgene LLC focused on the development and optimization of various viral gene-to-cell transfer delivery ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Glycan biomarker panels in liquid biopsies for predicting treatment response in lupus nephritis
SBC: GLYCOPATH INC Topic: 400Lupus nephritis (LN), an immune complex-mediated glomerulonephritis, affects up to two-thirds of patients with systemic lupus erythematosus. Despite standard treatment protocols, progression of the most aggressive forms of LN (class III and IV) to end-stage renal failure remains high. Thus, there is a need for biomarkers of therapeutic response that would allow physicians to make better-informed t ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Microfluidic technology platform as a continuous end-line process to inactivate pharmaceuticals
SBC: NIGHTHAWK BIOSCIENCES, INC. Topic: NCATSPROJECT SUMMARY To achieve the FDA’s required Sterility Assurance Level for use in humans, pharmaceutical products must undergo terminal sterilization or aseptic manufacturing. This can be accomplished using physical or chemical methods such as heat or formaldehyde for simple drug formulations; however, for pharmaceutical products that have more complex drug formulations or that contain biologic ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
A Therapeutic Role for Apolipoprotein-E in the Germ Theory of Alzheimer's Dementia
SBC: REGENNOVA, INC. Topic: RAbstract: A Therapeutic Role for Apolipoprotein-E in the Germ Theory of ADP. gingivalis is the keystone bacteria of periodontal disease, the 6th most common infectious disease worldwide. Half of all Americans over the age of 30 and 70% of those over age 65 suffer some degree of P. gingivalis infection associated with gum disease. In a study of 6800 patients with gum disease that were followed for ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health